Literature DB >> 28861886

Insights of Chinese medicine on ventricular remodeling: Multiple-targets, individualized-treatment.

Dan-Cai Fan1, Jian-Yong Qi1, Min-Zhou Zhang2.   

Abstract

Ventricular remodeling (VR) can be induced by myocardial injury, leading to progressive cardiac dysfunction and heart failure, and is associated with high morbidity and mortality. Despite being studied for more than 3 decades, current therapeutic strategies still remain unsatisfactory in effificacy, expensive, and with side effects and drug resistances. Chinese medicine (CM) has been used to treat heart diseases for thousands of years. This article reviews the published studies on the mechanisms and therapeutic applications of CM in VR. The major aspects include: mechanistic studies of VR, molecular biology and myocardial functional studies of CM therapies on VR, and mechanism of CM therapies on VR.

Entities:  

Keywords:  Chinese medicine; heart failure; ventricular remodeling

Mesh:

Substances:

Year:  2017        PMID: 28861886     DOI: 10.1007/s11655-017-2415-y

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  30 in total

1.  [Effect of Shexiang Baoxin pill on coronary vasodilation by analysis of coronary angiography].

Authors:  Xian-Zhao Zhang; Ya-Min Hou; Zhi-Hong Ou
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2014-12

2.  Renal Denervation Attenuates Multi-Organ Fibrosis and Improves Vascular Remodeling in Rats with Transverse Aortic Constriction Induced Cardiomyopathy.

Authors:  Kai Wang; Dasheng Lu; Bin Zhang; Shengchan Wang; Qian Liu; Qi Zhang; Jie Geng; Qijun Shan
Journal:  Cell Physiol Biochem       Date:  2016-11-25

3.  Shexiang Tongxin dropping pill attenuates atherosclerotic lesions in ApoE deficient mouse model.

Authors:  Minqi Xiong; Chenglin Jia; Jingang Cui; Peiwei Wang; Xiaoye Du; Qinbo Yang; Yuling Zhu; Wenjian Wang; Teng Zhang; Yu Chen
Journal:  J Ethnopharmacol       Date:  2014-11-18       Impact factor: 4.360

4.  Targeting Dynamin 2 as a Novel Pathway to Inhibit Cardiomyocyte Apoptosis Following Oxidative Stress.

Authors:  Danchen Gao; Jian Yang; Yutao Wu; Qiwen Wang; Qiaoling Wang; En Yin Lai; Jianhua Zhu
Journal:  Cell Physiol Biochem       Date:  2016-11-02

5.  Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells.

Authors:  I Ahrens; H Domeij; S U Eisenhardt; D Topcic; M Albrecht; E Leitner; K Viitaniemi; J B Jowett; M Lappas; C Bode; I Haviv; K Peter
Journal:  Basic Res Cardiol       Date:  2011-05-12       Impact factor: 17.165

6.  Effects of renal sympathetic denervation on cardiac systolic function after myocardial infarction in rats.

Authors:  Jiqun Guo; Zhongxia Zhou; Zhenzhen Li; Qian Liu; Guoqing Zhu; Qijun Shan
Journal:  J Biomed Res       Date:  2015-06-10

7.  Mechanisms of Chinese Medicine Xinmailong's protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes.

Authors:  Jianyong Qi; Juan Yu; Yafang Tan; Renshan Chen; Wen Xu; Yanfen Chen; Jun Lu; Qin Liu; Jiashin Wu; Weiwang Gu; Minzhou Zhang
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

8.  Relationship among LRP1 expression, Pyk2 phosphorylation and MMP-9 activation in left ventricular remodelling after myocardial infarction.

Authors:  Elena Revuelta-López; Carol Soler-Botija; Laura Nasarre; Aleyda Benitez-Amaro; David de Gonzalo-Calvo; Antoni Bayes-Genis; Vicenta Llorente-Cortés
Journal:  J Cell Mol Med       Date:  2017-04-04       Impact factor: 5.310

9.  X indening oral liquid improves cardiac function of rats with chronic cardiac failure via TGF-ß1/Smad3 and p38 MAPK pathway.

Authors:  Yunliang Wei; Changsheng Guo; Jingsheng Zhao; Jun Yang; Weiguo Yi; Hong Liu; Xinwei Lin; Zhengchen Zhang
Journal:  Anatol J Cardiol       Date:  2017-01-17       Impact factor: 1.596

10.  Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial.

Authors:  Hongcai Shang; Junhua Zhang; Chen Yao; Baoyan Liu; Xiumei Gao; Ming Ren; Hongbao Cao; Guohua Dai; Weiliang Weng; Sainan Zhu; Hui Wang; Hongjuan Xu; Boli Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-14       Impact factor: 2.629

View more
  8 in total

1.  Utilizing Bioinformatics Technology to Explore the Potential Mechanism of Danggui Buxue Decoction against NSCLC.

Authors:  Bin Yu; Guangyao Lv; Muhammad Sohail; Zhiyong Li; Yanli Li; Meiyu Yu; Fuyou Sun; Hui Xu
Journal:  Dis Markers       Date:  2022-02-26       Impact factor: 3.434

Review 2.  Cellular and Molecular Mechanism of Traditional Chinese Medicine on Ventricular Remodeling.

Authors:  Yong-Chun Zhu; Bo Liang; Ning Gu
Journal:  Front Cardiovasc Med       Date:  2021-12-01

3.  Mechanism of Yangxin Tongmai Decoction in the Treatment of Coronary Heart Disease with Blood Stasis Syndrome Based on Network Pharmacology and Molecular Docking.

Authors:  Mengxue Zhang; Jia Liu; Xiangzhuo Zhang; Shumeng Zhang; Yujie Jiang; Zixuan Yu; Ting Xie; Yuxia Chen; Lingli Chen; Jie Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-30       Impact factor: 2.650

4.  LianXia Formula Granule Attenuates Cardiac Sympathetic Remodeling in Rats with Myocardial Infarction via the NGF/TrKA/PI3K/AKT Signaling Pathway.

Authors:  Sai-Sai Li; Nan Kang; Xiang-Lei Li; Jing Yuan; Ruby Ling; Ping Li; Jia-Li Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-11       Impact factor: 2.629

5.  The essential differences in microbial and chemical components of musk of different qualities secreted by captive male forest musk deer (Moschus berezovskii).

Authors:  Yan Wang; Mao Sun; Fan Chang; Jun Wang; Yan Wang; Jie Tang; Kun Zhang; Lei Gao; Xiaochang Xue; Yi Wan
Journal:  Microb Biotechnol       Date:  2022-01-31       Impact factor: 6.575

Review 6.  Hydrogen Sulfide (H2S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases.

Authors:  Lei Zhang; Yanan Wang; Yi Li; Lingli Li; Suowen Xu; Xiaojun Feng; Sheng Liu
Journal:  Front Pharmacol       Date:  2018-09-21       Impact factor: 5.810

7.  The Effect and Mechanism of Chinese Herbal Formula Sini Tang in Heart Failure after Myocardial Infarction in Rats.

Authors:  Yuhan Zhu; Jing Zhao; Qingqing Han; Zhen Wang; Zhaobo Wang; Xin Dong; Jiebai Li; Lei Liu; Xiaoxu Shen
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-27       Impact factor: 2.629

8.  Ginsenoside Rg2 alleviates myocardial fibrosis by regulating TGF-β1/Smad signalling pathway.

Authors:  Quanwei Wang; Wenwen Fu; Xiaofeng Yu; Huali Xu; Dayun Sui; Yeling Wang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.